Anavex Life Sciences Corp (AVXL)

10.74 -0.30 (-2.72%) USD  |  NASDAQ  |  Dec 31, 16:00
10.75 +0.01 (+0.09%) After-Hours: 20:00
More

Anavex Life Sciences Research and Development Expense (Annual): 41.84M for Sept. 30, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for AVXL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Avid Bioservices Inc --
Alaunos Therapeutics Inc 16.28M
SELLAS Life Sciences Group Inc 24.01M
Galectin Therapeutics Inc 32.13M
Oragenics Inc 15.49M